REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 116 filers reported holding REVANCE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 2.86 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $212,185 | -44.5% | 43,127 | -0.9% | 0.00% | -50.0% |
Q4 2023 | $382,339 | -19.9% | 43,497 | +4.5% | 0.00% | -33.3% |
Q3 2023 | $477,542 | -53.0% | 41,634 | +3.7% | 0.00% | -50.0% |
Q2 2023 | $1,016,298 | -19.0% | 40,154 | +3.0% | 0.01% | -25.0% |
Q1 2023 | $1,255,127 | +78.0% | 38,967 | +2.0% | 0.01% | +60.0% |
Q4 2022 | $705,024 | -23.4% | 38,192 | +12.1% | 0.01% | -28.6% |
Q3 2022 | $920,000 | +103.1% | 34,060 | +3.8% | 0.01% | +133.3% |
Q2 2022 | $453,000 | -33.4% | 32,810 | -5.9% | 0.00% | -25.0% |
Q1 2022 | $680,000 | +11.7% | 34,851 | -6.6% | 0.00% | +33.3% |
Q4 2021 | $609,000 | -43.1% | 37,304 | -2.9% | 0.00% | -50.0% |
Q3 2021 | $1,070,000 | -8.2% | 38,420 | -2.3% | 0.01% | +50.0% |
Q2 2021 | $1,166,000 | +13.8% | 39,333 | +7.2% | 0.00% | 0.0% |
Q1 2021 | $1,025,000 | -1.2% | 36,677 | +0.3% | 0.00% | 0.0% |
Q4 2020 | $1,037,000 | +9.6% | 36,580 | -2.8% | 0.00% | -20.0% |
Q3 2020 | $946,000 | +11.6% | 37,630 | +8.3% | 0.01% | +25.0% |
Q2 2020 | $848,000 | +87.6% | 34,732 | +13.7% | 0.00% | +100.0% |
Q1 2020 | $452,000 | -1.5% | 30,556 | +8.1% | 0.00% | 0.0% |
Q4 2019 | $459,000 | +27.1% | 28,263 | +1.6% | 0.00% | +100.0% |
Q3 2019 | $361,000 | -0.6% | 27,806 | -0.7% | 0.00% | 0.0% |
Q2 2019 | $363,000 | -5.5% | 28,000 | +14.8% | 0.00% | 0.0% |
Q1 2019 | $384,000 | -11.7% | 24,391 | +12.9% | 0.00% | -50.0% |
Q4 2018 | $435,000 | -19.6% | 21,605 | -0.8% | 0.00% | 0.0% |
Q3 2018 | $541,000 | -7.8% | 21,771 | +1.8% | 0.00% | 0.0% |
Q2 2018 | $587,000 | +10.8% | 21,378 | +24.3% | 0.00% | 0.0% |
Q1 2018 | $530,000 | -4.0% | 17,205 | +11.4% | 0.00% | 0.0% |
Q4 2017 | $552,000 | +33.3% | 15,440 | +2.7% | 0.00% | +100.0% |
Q3 2017 | $414,000 | +12.8% | 15,038 | +8.1% | 0.00% | 0.0% |
Q2 2017 | $367,000 | +40.1% | 13,914 | +10.5% | 0.00% | 0.0% |
Q1 2017 | $262,000 | +7.8% | 12,590 | +7.1% | 0.00% | 0.0% |
Q4 2016 | $243,000 | -99.9% | 11,756 | -0.3% | 0.00% | 0.0% |
Q3 2016 | $191,067,000 | +19.4% | 11,787 | +0.2% | 0.00% | 0.0% |
Q2 2016 | $160,058,000 | -13.5% | 11,769 | +10.9% | 0.00% | 0.0% |
Q1 2016 | $185,000,000 | -40.9% | 10,608 | +15.8% | 0.00% | 0.0% |
Q4 2015 | $313,000,000 | +108204.5% | 9,164 | -5.8% | 0.00% | 0.0% |
Q3 2015 | $289,000 | -99.9% | 9,725 | +6.1% | 0.00% | 0.0% |
Q2 2015 | $293,225,000 | +161.6% | 9,169 | +69.5% | 0.00% | – |
Q1 2015 | $112,108,000 | +22.4% | 5,408 | 0.0% | 0.00% | – |
Q4 2014 | $91,612,000 | +4.3% | 5,408 | +19.0% | 0.00% | – |
Q3 2014 | $87,874,000 | -42.9% | 4,546 | +0.5% | 0.00% | -100.0% |
Q2 2014 | $153,816,000 | – | 4,524 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 4,592,047 | $121,230,000 | 21.92% |
Rhenman & Partners Asset Management AB | 220,000 | $5,808,000 | 0.83% |
ArrowMark Colorado Holdings LLC | 2,045,862 | $54,011,000 | 0.67% |
Vivo Capital, LLC | 77,373 | $2,043,000 | 0.52% |
Ghost Tree Capital, LLC | 89,295 | $2,357,000 | 0.49% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 124,932 | $3,298,000 | 0.47% |
Polar Capital LLP | 1,296,371 | $34,220,000 | 0.46% |
SUFFOLK CAPITAL MANAGEMENT LLC | 70,095 | $1,851,000 | 0.24% |
EAM Investors, LLC | 33,897 | $895,000 | 0.15% |
PointState Capital LP | 438,200 | $11,568,000 | 0.13% |